UB
COLL icon

UMB Bank’s Collegium Pharmaceutical COLL Stock Holding History

UMB Bank’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11K Sell
305
-16
-5% -$547 ﹤0.01% 1903
2026
Q1 		$10.6K Buy
321
+74
+30% +$3.13K ﹤0.01% 1833
2025
Q4 		$11.4K Buy
247
+89
+56% +$3.72K ﹤0.01% 1775
2025
Q3 		$5.53K Buy
158
+142
+888% +$4.94K ﹤0.01% 1854
2025
Q2 		$473 Sell
16
-130
-89% -$3.71K ﹤0.01% 2074
2025
Q1 		$4.36K Buy
+146
New +$4.46K ﹤0.01% 1798
2024
Q4 		– Sell
-78
Closed -$3.01K – 2094
2024
Q3 		$3.01K Buy
78
+39
+100% +$1.39K ﹤0.01% 1877
2024
Q2 		$1.26K Buy
39
+25
+179% +$867 ﹤0.01% 1914
2024
Q1 		$543 Buy
+14
New +$490 ﹤0.01% 1961

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

UMB Bank's COLL Position: Q2 2026 in Review

UMB Bank reduced its Collegium Pharmaceutical (COLL) stake by 5% in Q2 2026, selling an estimated $547 and leaving 305 shares worth $11K. The position accounts for ﹤0.01% of the portfolio, ranked #1903.

UMB Bank first reported a position in COLL in Q1 2024 and has held it in 9 quarters since. The position peaked at $11.4K in Q4 2025. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • UMB Bank held 305 shares of Collegium Pharmaceutical worth $11K as of Q2 2026.
  • UMB Bank sold 16 Collegium Pharmaceutical shares in Q2 2026, an estimated $547.
  • Collegium Pharmaceutical made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #1903 holding.
  • UMB Bank first reported a position in Collegium Pharmaceutical in Q1 2024 and has held it in 9 quarters since.
  • UMB Bank's Collegium Pharmaceutical position peaked at $11.4K in Q4 2025.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.